Trademark: 75191196
Status Date
Saturday, May 16, 2009
Registration Number
2194159
Registration Date
Tuesday, October 6, 1998
Filing Date
Friday, November 1, 1996
Published for Opposition
Tuesday, September 30, 1997
Cancellation Date
Saturday, May 16, 2009
5 formulated nucleic acid pharmaceutical preparations for the treatment of autoimmune diseases, acquired diseases in the nature of coronary artery disease, lung cancer, and melanoma, and genetic diseases in the nature of cystic fibrosis, asthma, breast cancer, and ovarian cancer
The mark consists, in part, of a stylized representation of an hourglass.
May 16, 2009
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Aug 7, 2007
Case File In Ticrs
Oct 27, 2004
Registered - Sec. 8 (6-Yr) Accepted
Oct 6, 2004
Registered - Sec. 8 (6-Yr) Filed
Oct 6, 2004
Teas Section 8 Received
Jan 2, 2004
Teas Change Of Correspondence Received
Oct 6, 1998
Registered-Principal Register
Aug 17, 1998
Allowed Principal Register - Sou Accepted
Jul 15, 1998
Assigned To Examiner
Jul 9, 1998
Statement Of Use Processing Complete
Jul 9, 1998
Extension 1 Granted
Jun 23, 1998
Use Amendment Filed
Jun 23, 1998
Extension 1 Filed
Dec 23, 1997
Noa Mailed - Sou Required From Applicant
Sep 30, 1997
Published For Opposition
Aug 29, 1997
Notice Of Publication
Jul 23, 1997
Approved For Pub - Principal Register
Jun 19, 1997
Correspondence Received In Law Office
May 28, 1997
Non-Final Action Mailed
May 13, 1997
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
